Haematologica (Jul 2024)
A transgenic mouse model of Down syndrome acute lymphoblastic leukemia identifies targetable vulnerabilities
- Jacob J. Junco,
- Max Rochette,
- Michelle Alozie,
- Raushan Rashid,
- Maci Terrell,
- Barry Zorman,
- Pavel Sumazin,
- Lauren Rowland,
- Gino Dettorre,
- Reid T. Powell,
- Clifford C. Stephan,
- Peter J. Davies,
- Margarita Martinez-Moczygemba,
- Jun J. Yang,
- Karen R. Rabin
Affiliations
- Jacob J. Junco
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
- Max Rochette
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
- Michelle Alozie
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
- Raushan Rashid
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
- Maci Terrell
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
- Barry Zorman
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
- Pavel Sumazin
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
- Lauren Rowland
- Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
- Gino Dettorre
- Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
- Reid T. Powell
- Institute of Biosciences and Technology, Texas A-M University, Houston, TX, USA; Department of Translational Medical Sciences, School of Medicine, Texas A-M University, Houston, TX
- Clifford C. Stephan
- Institute of Biosciences and Technology, Texas A-M University, Houston, TX, USA; Department of Translational Medical Sciences, School of Medicine, Texas A-M University, Houston, TX
- Peter J. Davies
- Institute of Biosciences and Technology, Texas A-M University, Houston, TX, USA; Department of Translational Medical Sciences, School of Medicine, Texas A-M University, Houston, TX
- Margarita Martinez-Moczygemba
- Institute of Biosciences and Technology, Texas A-M University, Houston, TX, USA; Department of Translational Medical Sciences, School of Medicine, Texas A-M University, Houston, TX
- Jun J. Yang
- Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN
- Karen R. Rabin
- Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX
- DOI
- https://doi.org/10.3324/haematol.2023.284761
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
